Capital Report: No Fountain of Youth: FDA and NIH Review Off-Label Use of Hormones

Hastings Center Report 33 (4):8 (2003)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,063

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The curious case of off-label use.Rebecca Dresser - 2007 - Hastings Center Report 37 (3):9-11.
Research Review at NIH.Mortimer B. Lipsett, John C. Fletcher & Marian Secundy - 1979 - Hastings Center Report 9 (1):18-21.
policy and politics: Speaking Off Label.Stephen R. Latham - forthcoming - Hastings Center Report.
Perspective: The FDA and Helsinki.Stuart Rennie - forthcoming - Hastings Center Report.
The FDA and Helsinki.Stuart Rennie - 2009 - Hastings Center Report 39 (3):3-3.
An NIH Panel's Early Warnings.Harold P. Green - 1984 - Hastings Center Report 14 (5):13-15.
At Law: Human Cloning and the FDA.Rebecca Dresser - 2003 - Hastings Center Report 33 (3):7.

Analytics

Added to PP
2013-11-22

Downloads
34 (#655,824)

6 months
14 (#215,666)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references